Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness

Author(s): Wu N | Chen SY | Lee YC | Zhao Y
Volume: 2013
Issue: default
Year: 2013

Cost of noninfectious comorbidities in patients with HIV

Author(s): Guaraldi G | Zona S | Menozzi M | Carli F | Bagni P | Berti A | Rossi E | Orlando G | Zoboli G | Palella F
Volume: 2013
Issue: default
Year: 2013

Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population

Author(s): Chen SY | Crivera C | Stokes M | Boulanger L | Schein J
Volume: 2013
Issue: default
Year: 2013

A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends

Author(s): Maniadakis N | Kapaki V | Damianidi L | Kourlaba G
Volume: 2013
Issue: default
Year: 2013

Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany

Author(s): Klussmann JP | Schädlich PK | Chen X | Rémy V
Volume: 2013
Issue: default
Year: 2013

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

Author(s): Kiiskinen U | Matthaei S | Reaney M | Mathieu C | Östenson C-G | Krarup T | Theodorakis M | Kiljański J | Salaun-Martin C | Sapin H | Guerci B
Volume: 2013
Issue: default
Year: 2013

Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals

Author(s): Magee G | Zbrozek A
Volume: 2013
Issue: default
Year: 2013

Update on the management of cirrhosis – focus on cost-effective preventative strategies

Author(s): Neff GW | Kemmer N | Duncan C | Alsina A
Volume: 2013
Issue: default
Year: 2013

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

Author(s): Thavorncharoensap M | Teerawattananon Y | Natanant S | Kulpeng W | Yothasamut J | Werayingyong P
Volume: 2013
Issue: default
Year: 2013

Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina

Author(s): González L | Elgart JF | Calvo H | Gagliardino JJ
Volume: 2013
Issue: default
Year: 2013

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

Author(s): Montgomery W | Liu L | Stensl | MD | Xue HB | Treuer T | Ascher-Svanum H
Volume: 2013
Issue: default
Year: 2013

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Author(s): Lensberg BR | Drummond MF | Danchenko N | Despiégel N | François C
Volume: 2013
Issue: default
Year: 2013

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation

Author(s): Wex J | Sidhu M | Odeyemi I | Abou-Setta AM | Retsa P | Tombal B
Volume: 2013
Issue: default
Year: 2013

Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study

Author(s): Bank AJ | Obetz C | Konrardy A | Khan A | Pillai KM | McKinley BJ | Gage RM | Turnbull MA | Kenney WO
Volume: 2013
Issue: default
Year: 2013

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

Author(s): Colombo GL | Matteo SD | Antinori A | Medaglia M | Murachelli S | Rizzardini G
Volume: 2013
Issue: default
Year: 2013

Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs

Author(s): Baser O | Tangirala K | Wei W | Xie L
Volume: 2013
Issue: default
Year: 2013

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Author(s): Nadkarni A | Kalsekar I | You M | Forbes R | Hebden T
Volume: 2013
Issue: default
Year: 2013

The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?

Author(s): Odeyemi IA | Nixon J
Volume: 2013
Issue: default
Year: 2013

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin

Author(s): Stephens JM | Gao X | Patel DA | Verheggen BG | Shelbaya A | Haider S
Volume: 2013
Issue: default
Year: 2013

Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model

Author(s): Lee HY | Yang BM | Hong JM | Lee TJ | Kim BG | Kim JW | Kim YT | Kim YM | Kang S
Volume: 2013
Issue: default
Year: 2013

Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia

Author(s): Sills ES | Chiriac L | Vaughan D | Jones CA | Salem SA
Volume: 2013
Issue: default
Year: 2013

Epidemiology of falls and osteoporotic fractures: a systematic review

Author(s): Morrison A | Fan T | Sen SS | Weisenfluh L
Volume: 2013
Issue: default
Year: 2012

Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs

Author(s): Doig GS | Simpson F
Volume: 2013
Issue: default
Year: 2013

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Author(s): Sorenson C | Drummond M | Bhuiyan Khan B
Volume: 2013
Issue: default
Year: 2013

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden

Author(s): Wex J | Abou-Setta AM
Volume: 2013
Issue: default
Year: 2013

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy

Author(s): Mody R | Eisenberg D | Hou L | Kamat S | Singer J | Gerson LB
Volume: 2013
Issue: default
Year: 2013

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Author(s): Mencacci C | Di Sciascio G | Katz P | Ripellino C
Volume: 2013
Issue: default
Year: 2013

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Author(s): Borghi C | Ambrosioni E | Omboni S | Cicero AFG | Bacchelli S | Degli Esposti D | Novo S | Vinereanu D | Ambrosio G | Reggiardo G | Zava D
Volume: 2013
Issue: default
Year: 2013

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

Author(s): Campbell RS | Chaudhari P | Hays HD | Taylor RJ | Nathanson BH | Bozzette SA | Horn DL
Volume: 2013
Issue: default
Year: 2013

Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

Author(s): Dunlop W | Iqbal I | Khan I | Ouwens M | Heron L
Volume: 2013
Issue: default
Year: 2013

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States

Author(s): Khorana AA | Dalal MR | Lin J | Connolly GC
Volume: 2013
Issue: default
Year: 2013

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Author(s): Darbà J | Pérez-Álvarez N | Kaskens L | Holgado-Pérez S | Racketa J | Rejas J
Volume: 2013
Issue: default
Year: 2013

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

Author(s): Vergnenègre A | Borget I | Chouaid C
Volume: 2013
Issue: default
Year: 2013

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study

Author(s): Sicras-Mainar A | Díaz-Cerezo S | Sanz de Burgoa V | Navarro-Artieda R
Volume: 2013
Issue: default
Year: 2013

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

Author(s): Reynolds MR | Nilsson J | Åkerborg Ö | Jhaveri M | Lindgren P
Volume: 2013
Issue: default
Year: 2013

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

Author(s): Degli Esposti L | Saragoni S | Buda S | Sturani A | Degli Esposti E
Volume: 2013
Issue: default
Year: 2013

Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States

Author(s): Knight T | Schaefer C | Chandran A | Zlateva G | Winkelmann A | Perrot S
Volume: 2013
Issue: default
Year: 2013

A cost-of-illness study of spina bifida in Italy

Author(s): Colombo GL | Di Matteo S | Vinci M | Gatti C | Pascali MP | De Gennaro M | Macrellino E | Mosiello G | Redaelli T | Schioppa F | Dieci C
Volume: 2013
Issue: default
Year: 2013

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Author(s): Walzer S | Travers K | Rieder S | Erazo-Fischer E | Matusiewicz D
Volume: 2013
Issue: default
Year: 2013

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

Author(s): O'Day K | Rajagopalan K | Meyer K | Pikalov A | Loebel A
Volume: 2013
Issue: default
Year: 2013

Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database

Author(s): Reed C | Hong J | Novick D | Lenox-Smith A | Happich M
Volume: 2013
Issue: default
Year: 2013

The costs of traumatic brain injury: a literature review

Author(s): Humphreys I | Wood RL | Phillips CJ | Macey S
Volume: 2013
Issue: default
Year: 2013

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

Author(s): Foroutan N | Rasekh HR | Salamzadeh J | Jamshidi HR | Nafar M
Volume: 2013
Issue: default
Year: 2013

The clinical and economic burden of chronic obstructive pulmonary disease in the USA

Author(s): Guarascio AJ | Ray SM | Finch CK | Self TH
Volume: 2013
Issue: default
Year: 2013

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

Author(s): Pinto SL | Kumar J | Partha G | Bechtol RA
Volume: 2013
Issue: default
Year: 2013

Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model

Author(s): Fragoulakis V | Maniadakis N
Volume: 2013
Issue: default
Year: 2013

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Author(s): Lazzaro C | Bordonaro R | Cognetti F | Fabi A | De Placido S | Arpino G | Marchetti P | Botticelli A | Pronzato P | Martelli E
Volume: 2013
Issue: default
Year: 2013

Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study

Author(s): Degli Esposti L | Didoni G | Simon T | Buda S | Sangiorgi D | Degli Esposti E
Volume: 2013
Issue: default
Year: 2012

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Author(s): Henk HJ | Chen C | Benedict A | Sullivan J | Teitelbaum A
Volume: 2013
Issue: default
Year: 2013

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen

Author(s): Colombo GL | Di Matteo S | Maggiolo F
Volume: 2013
Issue: default
Year: 2013